
| Medical Research | Dr. Zhang
Importance of VEGF Levels in Cancer Therapy Monitoring
Understanding how VEGF biomarkers can guide treatment decisions and monitor therapeutic efficacy in cancer patients...
Read More +Early detection and broad-spectrum cancer screening with VEGF kits
Read More +Comprehensive diagnostic solutions for diabetes, kidney diseases, and pregnancy monitoring
Read More +Pioneer researcher in VEGF diagnostic technology
Practitioner of Folkman theory
Extensive contributions to cancer research and angiogenesis diagnostics
Who We Are
Founded in 2002 in Zhongguancun, Beijing, we are pioneers in VEGF diagnostic technology with over two decades of innovation and excellence.
We developed the world's first government-approved VEGF (ELISA) diagnostic kit in 2011, establishing ourselves as the global leader in VEGF diagnostic reagent production with high-quality monoclonal antibodies and antigen technologies.
Our commitment to excellence in precision and accuracy has made us the trusted choice for VEGF diagnostics worldwide, with standards that exceed industry requirements.
Our Specialists
Our team of renowned specialists brings decades of experience in oncology, biomarker research, and VEGF testing. Each expert is dedicated to advancing cancer treatment through innovative diagnostic solutions.
What They Say
Hear from patients who have experienced the benefits of our advanced VEGF testing and monitoring services.
VEGF testing transformed my cancer treatment. Quick, accurate monitoring gave me peace of mind and clarity on my progress. The team's expertise and compassionate care made all the difference in my journey.
The precision of VEGF biomarker testing helped my oncologist adjust my treatment plan effectively. I felt confident knowing my progress was being monitored with such advanced technology.
As a researcher studying angiogenesis, I appreciate the accuracy and reliability of their VEGF testing kits. The results have been consistent and invaluable for my work.
Clinical Applications
VEGF testing provides crucial insights for various clinical scenarios, enabling healthcare professionals to make informed decisions in cancer management, diabetes monitoring, and pregnancy care.
VEGF biomarker testing helps guide targeted therapy decisions and predict treatment response in cancer patients.
learn more +Continuous VEGF monitoring enables early detection of cancer recurrence and metastatic progression.
learn more +VEGF levels provide valuable insights into patient prognosis and therapeutic effectiveness assessment.
learn more +Monitor VEGF levels to assess diabetic complications including retinopathy and nephropathy progression.
learn more +VEGF testing supports early detection and management of preeclampsia and eclampsia in pregnancy care.
learn more +our blog
Stay informed with the latest developments in VEGF research, cancer diagnostics, and therapeutic innovations.
| Medical Research | Dr. Zhang
Understanding how VEGF biomarkers can guide treatment decisions and monitor therapeutic efficacy in cancer patients...
Read More +| Diagnostics | Dr. Liu
Exploring how VEGF biomarkers enable earlier cancer detection and improved patient outcomes through advanced diagnostic techniques...
Read More +| Treatment Innovation | Dr. Wang
Discover the latest breakthroughs in anti-angiogenic therapies and how they're revolutionizing cancer treatment approaches...
Read More +Trusted by
Extensive clinical use across medical institutions and laboratories worldwide